Nutra Pharma Corp.
NPHC
$0.0003
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 577.20K | -645.80K | 5.01M | 2.17M | 15.43M |
| Total Depreciation and Amortization | 21.40K | 21.90K | 24.10K | 21.20K | 27.30K |
| Total Amortization of Deferred Charges | 137.00K | 133.90K | 133.60K | 94.30K | 94.20K |
| Total Other Non-Cash Items | -1.03M | 138.20K | -5.50M | -2.63M | -16.05M |
| Change in Net Operating Assets | 133.10K | 66.90K | 74.40K | 114.70K | 82.20K |
| Cash from Operations | -165.30K | -284.80K | -258.20K | -233.70K | -412.90K |
| Capital Expenditure | 0.00 | 0.00 | -58.00K | -4.30K | -4.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 48.30K | -10.50K | -4.00K | -12.00K | -92.00K |
| Cash from Investing | 48.30K | -10.50K | -62.00K | -16.30K | -96.60K |
| Total Debt Issued | 256.80K | 353.20K | 162.20K | 360.90K | 519.00K |
| Total Debt Repaid | -150.20K | -111.70K | -119.90K | -64.80K | -15.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 57.30K | 194.00K | -- | -- |
| Cash from Financing | 106.60K | 298.80K | 236.30K | 296.10K | 503.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.40K | 3.50K | -84.00K | 46.20K | -5.70K |